PIKFYVE: Inherited Retinal Disease Mechanisms and Translational Directions

projects

What problem are we solving?

Given its role in phagocytosis and its high expression in the retina, PIKFYVE is hypothesized to be important for the functions of the retinal pigment epithelium. With the increases in the applications of genetic sequencing and the identification of genetic variants, it is important to identify genes/proteins that have important roles in the retina in order to identify the causative genes for inherited retinal diseases. The field needs clearer mechanistic evidence and a defensible path from cellular phenotype to therapeutic hypotheses.

What we are doing

  • Characterizing relevant cellular pathways and phenotypes (wet-lab + analysis)
  • Connecting mechanistic findings to clinically meaningful readouts and potential interventions
  • Translational framing suitable for clinician audiences and future therapeutic work

My role

Primary experimental design/execution, analysis, interpretation, and manuscript development with emphasis on clinical relevance.

Current status

Core manuscript substantially developed; targeted experiments/analyses and writing integration ongoing.

Outputs

  • Review article
  • Primary research manuscript
  • Conference abstracts/talks/posters
Ehsan Misaghi
Authors
Clinician-Scientist Trainee
Ehsan Misaghi is an MD/PhD Candidate at the University of Alberta working at the intersection of ophthalmology, genetics, and artificial intelligence. His research focuses on inherited retinal disease and genotype–phenotype correlations in ocular disease, with an emphasis on mechanistic insight and translational relevance. Alongside research, he builds and evaluates practical AI tools for clinical and educational settings, and he leads medical AI education, research, and community-building through the AI in Medical Systems Society (AIMSS) and related initiatives. His goal is to advance rigorous, clinically useful research and translate it into improved diagnostics, care pathways, and responsible innovation.